| 中文名称: | 3-环丙基-1-(2-氟-4-碘苯基)-5-羟基-6,8-二甲基吡啶并[2,3-d]嘧啶-2,4,7-(1H,3H,8H)-三酮 |
| 中文别名: | 3-环丙基-1-(2-氟-4-碘苯基)-5-羟基-6,8-二甲基吡啶[2,3-d]并嘧啶-2,4,7-三酮;3-环丙基-1-(2-氟-4-碘苯基)-5-羟基-6,8-二甲基吡啶并[2,3-d]嘧啶-2,4,7(1h,3h,8h)-三酮;3-环己基-1-(2-氟-4-碘苯基)-5-羟基-6,8-二甲基吡啶并[2,3-d]嘧啶-2,4,7-(1H,3H,8H)-三酮;曲美替尼中间体;GSK1120212 中间体7 |
| smiles: | O=C1N(C2CC2)C(=O)N(C2C(F)=CC(I)=CC=2)C2=C1C(=C(C)C(N2C)=O)O |
| 英文名称: | 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione |
| 英文别名: | 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione;3H,8H)-trione;4,7(1H,3H,8H)-trione;MHHFXMZMCYWCJQ-UHFFFAOYSA-N;BCP14468;AK342731;3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,;3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethyl-1H,8H-pyrido[2,3-d]pyrimidine-2,4,7-trione;3-cyclopropyl-1-(2-fluor;CID 59717004;3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7-trione;AMY30034;WJB70024;F11735;3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione (ACI);3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethyl-1H,8H-pyrido[2,3-d]pyrimidine-2,4,7-trione;3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7-trione |
| CAS号: | 871700-24-2 |
| 分子式: | C18H15FIN3O4 |
| 分子量: | 483.23 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
3-环丙基-1-(2-氟-4-碘苯基)-5-羟基-6,8-二甲基吡啶并[2,3-d]嘧啶-2,4,7-(1H,3H,8H)-三酮
英文名:
3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione
别名:3-环丙基-1-(2-氟-4-碘苯基)-5-羟基-6,8-二甲基吡啶[2,3-d]并嘧啶-2,4,7-三酮;3-环丙基-1-(2-氟-4-碘苯基)-5-羟基-6,8-二甲基吡啶并[2,3-d]嘧啶-2,4,7(1h,3h,8h)-三酮;3-环己基-1-(2-氟-4-碘苯基)-5-羟基-6,8-二甲基吡啶并[2,3-d]嘧啶-2,4,7-(1H,3H,8H)-三酮;曲美替尼中间体;GSK1120212 中间体7
商品编号:R077404-250mg
规格:250mg
纯度:97%
CAS号: 871700-24-2
分子式:C18H15FIN3O4
分子量:483.23
| 价格 |
¥ 122.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















